IRRA - PT. Itama Ranoraya Tbk

Rp 2.480

-10 (-0,40%)

JAKARTA - During the first nine months of 2020 (9M2020), PT Itama Ranoraya Tbk (IRRA) managed to record revenue of Rp141.06 billion or grew 9.4% compared to the same period last year.

The company's revenue contribution came from Non-Electromedical Medical Devices (Syringes), which grew 19.3% (YoY) to Rp33.14 billion. And In Vitro Diagnostic Products which grew by 6.5% (YoY) to Rp107.77 billion.

The company's operating profit that was achieved until 9M2020 was Rp11.36 billion or grew 31.8% compared to the same period last year which was recorded at Rp8.6 billion. Meanwhile, net profit grew even higher by 46.4% to Rp9.03 billion.

High growth in operating profit and net profit was also accompanied by an increase in profit quality in the form of profit margin. IRRA's operating profit and net profit margins increased by 137 bps and 162 bps to 8.1% and 6.4%, respectively. (LM)